• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Thomas H. Lee Partners Appoints Paul Black As a Consultant for Healthcare Group

    10/11/22 9:00:00 AM ET
    $CERN
    $HQY
    $MDRX
    Managed Health Care
    Health Care
    Business Services
    Consumer Discretionary
    Get the next $CERN alert in real time by email

    Healthcare IT Industry Expert Will Support the Firm's HCIT Strategy

    Thomas H. Lee Partners, L.P. ("THL"), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firm's healthcare investment group. Black, who brings more than 25 years of experience leading companies in healthcare information technology ("Healthcare IT"), will support the team's efforts in identifying, sourcing, and growing investment opportunities across the healthcare market.

    "We are very pleased to welcome Paul to THL as a consultant for the firm's healthcare group," said Shahab Vagefi, Managing Director at THL. "THL has had a longstanding focus in healthcare and technology. As we continue finding investment opportunities at the intersection of these industries, Paul's significant experience creating and executing a strategic vision for businesses in Healthcare IT will be greatly beneficial as we add more high-quality companies seeking to improve the healthcare ecosystem to our portfolio."

    In this role, Black will support the healthcare group in deal sourcing, due diligence for potential investments, and developing new relationships with founders and management teams across the healthcare landscape. He will also serve as an advisor to portfolio companies to support their growth.

    "THL's thesis-driven approach and dedicated focus on Healthcare IT has enabled it to work with unique companies across the healthcare landscape," said Paul Black. "I am pleased to join such an exceptional team and look forward to advancing the firm's strategy."

    Prior to joining THL, Black served 10 years as a Director and CEO of Allscripts, (NASDAQ:MDRX) a global leader in healthcare information technology solutions. Before that, he was the COO of Cerner Corporation (NASDAQ:CERN) for more than a decade. Black is currently a director of HealthEquity (NASDAQ:HQY), Community CareLink, The Advancement Board University of Kansas Health System and The Harry S. Truman Presidential Library & Museum.

    About Thomas H. Lee Partners, L.P.

    Thomas H. Lee Partners, L.P. ("THL") is a premier private equity firm investing in middle-market growth companies exclusively within three sectors: Healthcare, Financial Technology & Services, and Technology & Business Solutions. THL couples deep sector expertise through an Identified Sector Opportunity ("ISO") process with dedicated internal operating resources from its Strategic Resource Group ("SRG") to transform and build great companies of lasting value in partnership with management. The Firm's domain expertise and resources help to build great companies with an aim to accelerate growth, improve operations and drive long-term sustainable value. THL has been an active investor in Healthcare and Healthcare IT for decades with investments in Intelligent Medical Objects, Nextech, Qventus, Intermedix, SeniorLink and numerous other Healthcare and Technology companies. Since 1974, THL has raised more than $34 billion of equity capital, invested in over 160 companies and completed more than 500 add-on acquisitions representing an aggregate enterprise value at acquisition of over $210 billion.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20221011005107/en/

    Get the next $CERN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CERN
    $HQY
    $MDRX

    CompanyDatePrice TargetRatingAnalyst
    HealthEquity Inc.
    $HQY
    5/22/2025$105.00 → $112.00Outperform
    RBC Capital Mkts
    HealthEquity Inc.
    $HQY
    3/25/2025$120.00 → $115.00Outperform → Strong Buy
    Raymond James
    HealthEquity Inc.
    $HQY
    12/4/2024$126.00Outperform
    Mizuho
    HealthEquity Inc.
    $HQY
    11/15/2024$108.00Neutral
    Goldman
    HealthEquity Inc.
    $HQY
    4/4/2024$101.00Mkt Outperform
    JMP Securities
    HealthEquity Inc.
    $HQY
    4/2/2024$86.00 → $108.00Overweight
    JP Morgan
    Veradigm Inc.
    $MDRX
    3/19/2024$15.00 → $10.00Buy → Hold
    Deutsche Bank
    Veradigm Inc.
    $MDRX
    1/3/2024$11.00Equal Weight
    Barclays
    More analyst ratings